Free tool
Cell therapy stocks
We cover 11 companies grouped under the Cell therapy theme. The median market value in the group is $54.52M. Across the group, the median move over the past trading day is +0.54%. Price change over the past year runs from −50.3% to +27.7% across the middle 80 percent of the group, with a median of −23.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| SYNC.L | Syncona Limited | $933.97M | Small cap | +17.03% |
| 0HX7.L | Adicet Bio, Inc. | $415.26M | Small cap | −28.19% |
| ALCLS.PA | Cellectis S.A. | $355.75M | Small cap | +27.74% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $124.82M | Small cap | −23.28% |
| V3V.DE | FamiCord AG | $58.74M | Micro cap | −61.35% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $54.52M | Micro cap | +70.43% |
| PTG.WA | Poltreg S.A. | $34.78M | Micro cap | −14.68% |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% |
| F98.F | CytoMed Therapeutics Limited | $10.76M | Micro cap | −50.30% |
| 0QFK.L | Celyad Oncology SA | $4.54M | Micro cap | −9.18% |
| BSFA.L | BSF Enterprise Plc | $3.03M | Micro cap | −48.89% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.